Trait Information | |
Identifier | MONDO_0001134 |
Description | Hypertension that presents without an identifiable cause. [NCIT: P378] | Trait category |
Cardiovascular disease
|
Synonyms |
2 synonyms
|
Mapped terms |
9 mapped terms
|
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS000957 (GBE_HC932) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Essential (primary hypertension) (time-to-event) | essential hypertension | 11,276 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000957/ScoringFiles/PGS000957.txt.gz |
PGS000958 (GBE_HC273) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Essential hypertension | essential hypertension | 9,400 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000958/ScoringFiles/PGS000958.txt.gz |
PGS004456 (disease.I10.score) |
PGP000561 | Jung H et al. Commun Biol (2024) |
I10 (Essential (primary) hypertension) | essential hypertension | 1,059,939 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004456/ScoringFiles/PGS004456.txt.gz |
PGS004526 (meta.I10.score) |
PGP000561 | Jung H et al. Commun Biol (2024) |
I10 (Essential (primary) hypertension) | essential hypertension | 1,059,939 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004526/ScoringFiles/PGS004526.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM007609 | PGS000957 (GBE_HC932) |
PSS004711| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE essential (primary hypertension) | — | AUROC: 0.71865 [0.70527, 0.73203] | R²: 0.17042 Incremental AUROC (full-covars): -0.00133 PGS R2 (no covariates): 0.00389 PGS AUROC (no covariates): 0.53092 [0.51597, 0.54587] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007610 | PGS000957 (GBE_HC932) |
PSS004712| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE essential (primary hypertension) | — | AUROC: 0.7519 [0.72118, 0.78262] | R²: 0.18828 Incremental AUROC (full-covars): 0.01726 PGS R2 (no covariates): 0.02831 PGS AUROC (no covariates): 0.59059 [0.55566, 0.62552] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007611 | PGS000957 (GBE_HC932) |
PSS004713| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE essential (primary hypertension) | — | AUROC: 0.74724 [0.74015, 0.75433] | R²: 0.19436 Incremental AUROC (full-covars): 0.02015 PGS R2 (no covariates): 0.03223 PGS AUROC (no covariates): 0.60027 [0.59183, 0.6087] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007612 | PGS000957 (GBE_HC932) |
PSS004714| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE essential (primary hypertension) | — | AUROC: 0.73072 [0.71892, 0.74253] | R²: 0.19598 Incremental AUROC (full-covars): 0.00857 PGS R2 (no covariates): 0.01913 PGS AUROC (no covariates): 0.56924 [0.55569, 0.58279] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007613 | PGS000957 (GBE_HC932) |
PSS004715| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE essential (primary hypertension) | — | AUROC: 0.72352 [0.71925, 0.72779] | R²: 0.16706 Incremental AUROC (full-covars): 0.02959 PGS R2 (no covariates): 0.04055 PGS AUROC (no covariates): 0.60837 [0.60349, 0.61326] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007614 | PGS000958 (GBE_HC273) |
PSS004403| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Essential hypertension | — | AUROC: 0.72155 [0.708, 0.7351] | R²: 0.17503 Incremental AUROC (full-covars): -0.00192 PGS R2 (no covariates): 0.00286 PGS AUROC (no covariates): 0.52821 [0.51311, 0.54331] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007615 | PGS000958 (GBE_HC273) |
PSS004404| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Essential hypertension | — | AUROC: 0.74478 [0.71204, 0.77751] | R²: 0.16987 Incremental AUROC (full-covars): 0.01358 PGS R2 (no covariates): 0.01557 PGS AUROC (no covariates): 0.56972 [0.5318, 0.60763] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007616 | PGS000958 (GBE_HC273) |
PSS004405| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Essential hypertension | — | AUROC: 0.74583 [0.73846, 0.75319] | R²: 0.1847 Incremental AUROC (full-covars): 0.01683 PGS R2 (no covariates): 0.02709 PGS AUROC (no covariates): 0.59474 [0.58596, 0.60351] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007617 | PGS000958 (GBE_HC273) |
PSS004406| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Essential hypertension | — | AUROC: 0.73161 [0.71966, 0.74357] | R²: 0.19538 Incremental AUROC (full-covars): 0.00693 PGS R2 (no covariates): 0.01804 PGS AUROC (no covariates): 0.56789 [0.55414, 0.58165] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007618 | PGS000958 (GBE_HC273) |
PSS004407| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Essential hypertension | — | AUROC: 0.72364 [0.71923, 0.72805] | R²: 0.16114 Incremental AUROC (full-covars): 0.02564 PGS R2 (no covariates): 0.03436 PGS AUROC (no covariates): 0.60148 [0.5964, 0.60656] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM020571 | PGS004456 (disease.I10.score) |
PSS011364| European Ancestry| 56,192 individuals |
PGP000561 | Jung H et al. Commun Biol (2024) |
Reported Trait: I10 (Essential (primary) hypertension) | OR: 1.47509 | — | — | — | — |
PPM020641 | PGS004526 (meta.I10.score) |
PSS011364| European Ancestry| 56,192 individuals |
PGP000561 | Jung H et al. Commun Biol (2024) |
Reported Trait: I10 (Essential (primary) hypertension) | OR: 1.54547 | — | — | — | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011364 | — | — | 56,192 individuals | — | European | — | UKB | — |
PSS004711 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004712 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004713 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004714 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004715 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004403 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004404 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004405 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004406 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004407 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |